Jason Paul Smith

Dr. Jason Paul Smith

University of Virginia Health System, Charlottesville, Virginia, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in NAR Genomics and Bioinformatics
Verified
Journal Article
Open access
PDF file
JSJason Paul Smith
Jason Paul Smith
MCM Ryan Corces
M Ryan Corces
JXJin Xu
Jin Xu
VRVincent P Reuter
Vincent P Reuter
HCHoward Y Chang
Howard Y Chang
NSNathan Sheffield
Nathan Sheffield
As chromatin accessibility data from ATAC-seq experiments continues to expand, there is continuing need for standardized analysis pipelines. Here, we present PEPATAC, an ATAC-seq pipeline that is easily applied to ATAC-seq projects of any size, from one-off experiments to large-scale sequencing projects. PEPATAC leverages unique features of ATAC-seq data to optimize for speed and accuracy, and it provides several unique analytical approaches. Output includes convenient quality control plots, summary statistics, and a variety of generally useful data formats to set the groundwork for subsequent project-specific data analysis. Downstream analysis is simplified by a standard definition format, modularity of components, and metadata APIs in R and Python. It is restartable, fault-tolerant, and can be run on local hardware, using any cluster resource manager, or in provided Linux containers. We also demonstrate the advantage of aligning to the mitochondrial genome serially, which improves the accuracy of alignment statistics and quality control metrics. PEPATAC is a robust and portable first step for any ATAC-seq project. BSD2-licensed code and documentation are available at https://pepatac.databio.org.

29 January 2020 in GigaScience
Verified
Journal Article
Open access
PDF file
MSMichał Stolarczyk
Michał Stolarczyk
VRVincent P Reuter
Vincent P Reuter
JSJason Paul Smith
Jason Paul Smith
NMNeal E Magee
Neal E Magee
NSNathan Sheffield
Nathan Sheffield
Reference genome assemblies are essential for high-throughput sequencing analysis projects. Typically, genome assemblies are stored on disk alongside related resources; e.g., many sequence aligners require the assembly to be indexed. The resulting indexes are broadly applicable for downstream analysis, so it makes sense to share them. However, there is no simple tool to do this. Here, we introduce refgenie, a reference genome assembly asset manager. Refgenie makes it easier to organize, retrieve, and share genome analysis resources. In addition to genome indexes, refgenie can manage any files related to reference genomes, including sequences and annotation files. Refgenie includes a command line interface and a server application that provides a RESTful API, so it is useful for both tool development and analysis. Refgenie streamlines sharing genome analysis resources among groups and across computing environments. Refgenie is available at https://refgenie.databio.org.

22 June 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
EDEliza Duvall
Eliza Duvall
CBCecil M. Benitez
Cecil M. Benitez
KTKrissie Tellez
Krissie Tellez
MEMartin Enge
Martin Enge
PPPhilip T. Pauerstein
Philip T. Pauerstein
HAH. Efsun Arda
H. Efsun Arda
Delineating gene regulatory networks that orchestrate cell-type specification is a continuing challenge for developmental biologists. Single-cell analyses offer opportunities to address these challenges and accelerate discovery of rare cell lineage relationships and mechanisms underlying hierarchical lineage decisions. Here, we describe the molecular analysis of mouse pancreatic endocrine cell differentiation using single-cell transcriptomics, chromatin accessibility assays coupled to genetic labeling, and cytometry-based cell purification. We uncover transcription factor networks that delineate β-, α-, and δ-cell lineages. Through genomic footprint analysis, we identify transcription factor–regulatory DNA interactions governing pancreatic cell development at unprecedented resolution. Our analysis suggests that the transcription factor Neurog3 may act as a pioneer transcription factor to specify the pancreatic endocrine lineage. These findings could improve protocols to generate replacement endocrine cells from renewable sources, like stem cells, for diabetes therapy.

12 April 2022 in BMC Genomics
Verified
Journal Article
Open access
PDF file
KKKristyna Kupkova
Kristyna Kupkova
JMJose Verdezoto Mosquera
Jose Verdezoto Mosquera
JSJason Paul Smith
Jason Paul Smith
MSMichał Stolarczyk
Michał Stolarczyk
TDTessa L. Danehy
Tessa L. Danehy
NSNathan Sheffield
Nathan Sheffield
Background: Epigenome analysis relies on defined sets of genomic regions output by widely used assays such as ChIP-seq and ATAC-seq. Statistical analysis and visualization of genomic region sets is essential to answer biological questions in gene regulation. As the epigenomics community continues generating data, there will be an increasing need for software tools that can efficiently deal with more abundant and larger genomic region sets. Here, we introduce GenomicDistributions, an R package for fast and easy summarization and visualization of genomic region data.Results: GenomicDistributions offers a broad selection of functions to calculate properties of genomic region sets, such as feature distances, genomic partition overlaps, and more. GenomicDistributions functions are meticulously optimized for best-in-class speed and generally outperform comparable functions in existing R packages. GenomicDistributions also offers plotting functions that produce editable ggplot objects. All GenomicDistributions functions follow a uniform naming scheme and can handle either single or multiple region set inputs.Conclusions: GenomicDistributions offers a fast and scalable tool for exploratory genomic region set analysis and visualization. GenomicDistributions excels in user-friendliness, flexibility of outputs, breadth of functions, and computational performance. GenomicDistributions is available from Bioconductor (https://bioconductor.org/packages/release/bioc/html/GenomicDistributions.html).

25 October 2024 in Circulation Research
Verified
Journal Article
Closed access
MYManako Yamaguchi
Manako Yamaguchi
LALucas Ferreira de Almeida
Lucas Ferreira de Almeida
HYHiroki Yamaguchi
Hiroki Yamaguchi
XLXiuyin Liang
Xiuyin Liang
JSJason Paul Smith
Jason Paul Smith
RGR. Ariel Gomez
R. Ariel Gomez

26 October 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
BMBenjamin B. Morris
Benjamin B. Morris
JSJason Paul Smith
Jason Paul Smith
QZQi Zhang
Qi Zhang
ZJZhijie Jiang
Zhijie Jiang
OHOliver A. Hampton
Oliver A. Hampton
MMMarty W Mayo
Marty W Mayo
In the past decade, defective DNA repair has been increasingly linked with cancer progression. Human tumors with markers of defective DNA repair and increased replication stress exhibit genomic instability and poor survival rates across tumor types. Seminal studies have demonstrated that genomic instability develops following inactivation of BRCA1, BRCA2, or BRCA-related genes. However, it is recognized that many tumors exhibit genomic instability but lack BRCA inactivation. We sought to identify a pan-cancer mechanism that underpins genomic instability and cancer progression in BRCA-wildtype tumors. Methods: Using multi-omics data from two independent consortia, we analyzed data from dozens of tumor types to identify patient cohorts characterized by poor outcomes, genomic instability, and wildtype BRCA genes. We developed several novel metrics to identify the genetic underpinnings of genomic instability in tumors with wildtype BRCA. Associated clinical data was mined to analyze patient responses to standard of care therapies and potential differences in metastatic dissemination. Results: Systematic analysis of the DNA repair landscape revealed that defective single-strand break repair, translesion synthesis, and non-homologous end-joining effectors drive genomic instability in tumors with wildtype BRCA and BRCA-related genes. Importantly, we find that loss of these effectors promotes replication stress, therapy resistance, and increased primary carcinoma to brain metastasis. Conclusions: Our results have defined a new pan-cancer class of tumors characterized by replicative instability (RIN). RIN is defined by the accumulation of intra-chromosomal, gene-level gain and loss events at replication stress sensitive (RSS) genome sites. We find that RIN accelerates cancer progression by driving copy number alterations and transcriptional program rewiring that promote tumor evolution. Clinically, we find that RIN drives therapy resistance and distant metastases across multiple tumor types.